EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial

Yuki Matsuda, Shinsuke Kito, Yoshio Igarashi, Masahiro Shigeta

Neuropsychobiology · 2020 · 79 (3) · 208-213

DOI: 10.1159/000505405 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Neuropsychobiology, online erschienen am 17.01.2020. Verfasst von Yuki Matsuda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan, myuki@jikei.ac.jp. Hauptthemen laut MEDLINE: Outcome Assessment, Health Care, Transcranial Magnetic Stimulation. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Major depression is a highly prevalent disorder that causes economic burden in office workers. We conducted a randomized, double-blind, sham-controlled trial to evaluate the efficacy and safety of deep transcranial magnetic stimulation (dTMS) in office workers with treatment-resistant depression.

Methods

In this study, we randomized office workers taking administrative leave for treatment-resistant major depressive disorder or bipolar disorder with current major depressive episode. dTMS treatment was applied at 120% resting motor threshold with 18 Hz over the left dorsolateral prefrontal cortex. The treatment sessions delivered a total of 1,980 pulses a day, 5 days a week, for 4–6 weeks. The primary outcome was change in the total score on the 21-item Hamilton Depression Rating Scale (HDRS-21) from baseline to the end of study in an intent-to-treat analysis. The secondary outcomes were the response and remission rates. We also assessed changes in cognitive function and adverse events.

Results

Forty patients were randomized to active or sham dTMS groups (1:1). The change in the total score on the HDRS-21 was more significantly improved in the active group than in the sham group at 6 weeks (p = 0.045). There were no significant differences in the response and remission rates or cognitive measures between the active and sham groups. No serious adverse events were observed in either group.

Conclusions

These results suggest that dTMS might be effective and safe in office workers with treatment-resistant depression. Further well-designed studies are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Outcome Assessment, Health CareTranscranial Magnetic StimulationAdministrative PersonnelAdultAgedBipolar DisorderMajor Depressive DisorderDepressive Disorder, Treatment-ResistantDouble-Blind MethodFemaleHumansMaleMiddle AgedPlacebosPsychiatric Status Rating ScalesRemission InductionSeverity of Illness Index

Stichwörter der Autor:innen

Deep transcranial magnetic stimulationEfficacySafetyTreatment-resistant depressionWorker

Substanzen

Placebos

Autor:innen und Institutionen

  • Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan, myuki@jikei.ac.jp.
  • Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Psychiatry, Medical Care Toranomon Clinic, Tokyo, Japan.

Zitieren

APA

Matsuda, Y., Kito, S., Igarashi, Y., & Shigeta, M. (2020). Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial. Neuropsychobiology, 79(3), 208-213. https://doi.org/10.1159/000505405

Vancouver

Matsuda Y, Kito S, Igarashi Y, Shigeta M. Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial. Neuropsychobiology. 2020;79(3):208-213. doi:10.1159/000505405

BibTeX
@article{Matsuda2020,
  author = {Matsuda, Yuki and Kito, Shinsuke and Igarashi, Yoshio and Shigeta, Masahiro},
  title = {Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial},
  journal = {Neuropsychobiology},
  year = {2020},
  volume = {79},
  number = {3},
  pages = {208--213},
  doi = {10.1159/000505405}
}
Kostenlos starten →